Evidence map›Paper›PMID 41295364›Full record

ArticleJournal of cardiovascular development and disease2025

Role of P2X7 Receptor on Hypoxia-Induced Vascular Endothelial Growth Factor Gene Expression in H9c2 Rat Cardiomyocytes.

Anfal F Bin Dayel, Reem M Alhejji, Asma S Alonazi, Nouf M Alrasheed

Abstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anfal F Bin DayelDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-7138-414X
Reem M AlhejjiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Asma S AlonaziDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-3367-002X
Nouf M AlrasheedDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-5283-1576

Funding

Ongoing Research Funding program, King Saud University, Riyadh, Saudi Arabia (ORF-2025-1357)The Saudi National Institute for Health [SNIH-RO-HRT01-2302-KSU-36565]
6 · The paper itself

Abstract

Purinergic P2X7 receptors (P2X7Rs) may provide cardioprotection against ischemic heart disease. Cardiac angiogenesis is an endogenous adaptive response of hypoxic cardiomyocytes, mediated by vascular endothelial growth factor (VEGF) via hypoxia-inducible factor-1α (HIF-1α). The study aimed to determine whether P2X7Rs can regulate cardiac pro-angiogenic signaling in hypoxic H9c2 cardiomyocytes by modulating the angiogenic factor VEGF through HIF-1α genes. H9c2 rat cardiomyocytes were exposed to hypoxia alone or in combination with the P2X7R antagonist A740003. Subsequently, ATP levels and LDH activity were measured. The expression of P2X7R, HIF-1α, and VEGF was detected. Intracellular ATP level was significantly lower in hypoxia cardiomyocytes, whereas extracellular ATP, HIF-1α, and LDH levels were significantly higher in hypoxic cardiomyocytes. These effects were associated with increased P2X7R and VEGF gene expressions. Pretreatment with A740003 reversed HIF-1α and VEGF expressions in hypoxic cardiomyocytes. The findings suggest that P2X7Rs regulate pro-angiogenic signaling in hypoxic cardiomyocytes through the HIF-1α/VEGF pathway. Thus, the P2X7R-mediated HIF-1α/VEGF pathway may represent a novel approach to stimulating angiogenesis and preventing heart failure in ischemic heart disease.

Indexed as

hypoxia-inducible factor-1αischemic heart diseasepurinergic P2X7 receptorsvascular endothelial growth factor

Identifiers

PMID41295364
PMCPMC12653796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.